RASL11A and neoplasm: Analysis of our RNA‐seq data and published RUNX3 ChIP‐seq data suggested that RASL11A might play a role in the tumor‐promoting ability of the exp‐CAFs and that it is under the control of RUNX3 at the transcription level.